Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Mechanism for improved insulin sensitivity after gastric bypass surgery.

Bikman BT, Zheng D, Pories WJ, Chapman W, Pender JR, Bowden RC, Reed MA, Cortright RN, Tapscott EB, Houmard JA, Tanner CJ, Lee J, Dohm GL.

J Clin Endocrinol Metab. 2008 Dec;93(12):4656-63. doi: 10.1210/jc.2008-1030. Epub 2008 Sep 2.

2.

Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.

Pereira JA, Lazarin MA, Pareja JC, de Souza A, Muscelli E.

Obes Res. 2003 Dec;11(12):1495-501.

3.

The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.

Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E.

J Clin Endocrinol Metab. 2011 Sep;96(9):E1372-9. doi: 10.1210/jc.2011-0446. Epub 2011 Jul 21.

PMID:
21778221
4.

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

Reed MA, Pories WJ, Chapman W, Pender J, Bowden R, Barakat H, Gavin TP, Green T, Tapscott E, Zheng D, Shankley N, Yieh L, Polidori D, Piccoli SP, Brenner-Gati L, Dohm GL.

J Clin Endocrinol Metab. 2011 Aug;96(8):2525-31. doi: 10.1210/jc.2011-0165. Epub 2011 May 18.

PMID:
21593117
5.

GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle.

Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP.

Physiol Genomics. 2006 Oct 11;27(2):114-21. Epub 2006 Jul 18.

6.

Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation.

Burstein R, Epstein Y, Charuzi I, Suessholz A, Karnieli E, Shapiro Y.

Int J Obes Relat Metab Disord. 1995 Aug;19(8):558-61.

PMID:
7489026
7.

Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.

Lee WJ, Chong K, Chen CY, Chen SC, Lee YC, Ser KH, Chuang LM.

Obes Surg. 2011 Jul;21(7):889-95. doi: 10.1007/s11695-011-0401-6.

PMID:
21499957
8.

Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.

Anderwald CH, Tura A, Promintzer-Schifferl M, Prager G, Stadler M, Ludvik B, Esterbauer H, Bischof MG, Luger A, Pacini G, Krebs M.

Diabetes Care. 2012 Dec;35(12):2580-7. doi: 10.2337/dc12-0197. Epub 2012 Aug 24.

9.

Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes.

Dadson P, Landini L, Helmiö M, Hannukainen JC, Immonen H, Honka MJ, Bucci M, Savisto N, Soinio M, Salminen P, Parkkola R, Pihlajamäki J, Iozzo P, Ferrannini E, Nuutila P.

Diabetes Care. 2016 Feb;39(2):292-9. doi: 10.2337/dc15-1447. Epub 2015 Dec 17.

PMID:
26681717
10.

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.

Hofsø D, Jenssen T, Bollerslev J, Ueland T, Godang K, Stumvoll M, Sandbu R, Røislien J, Hjelmesæth J.

Eur J Endocrinol. 2011 Feb;164(2):231-8. doi: 10.1530/EJE-10-0804. Epub 2010 Nov 15.

11.

Differential effect of weight loss on insulin resistance in surgically treated obese patients.

Muscelli E, Mingrone G, Camastra S, Manco M, Pereira JA, Pareja JC, Ferrannini E.

Am J Med. 2005 Jan;118(1):51-7.

PMID:
15639210
12.

GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism.

de Carvalho CP, Marin DM, de Souza AL, Pareja JC, Chaim EA, de Barros Mazon S, da Silva CA, Geloneze B, Muscelli E, Alegre SM.

Obes Surg. 2009 Mar;19(3):313-20. doi: 10.1007/s11695-008-9678-5. Epub 2008 Sep 25.

PMID:
18815849
13.

Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms underlying metabolic improvements.

Fellici AC, Lambert G, Lima MM, Pareja JC, Rodovalho S, Chaim EA, Geloneze B.

Obes Surg. 2015 Jan;25(1):36-44. doi: 10.1007/s11695-014-1377-9.

PMID:
25098565
14.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Bojsen-Møller KN.

Dan Med J. 2015 Apr;62(4):B5057. Review.

PMID:
25872541
15.

Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling.

Severino A, Castagneto-Gissey L, Raffaelli M, Gastaldelli A, Capristo E, Iaconelli A, Guidone C, Callari C, Bellantone R, Mingrone G.

Surg Obes Relat Dis. 2016 Jan;12(1):42-7. doi: 10.1016/j.soard.2015.06.005. Epub 2015 Jun 10.

PMID:
26483070
16.

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.

Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR.

Int J Obes (Lond). 2010 Mar;34(3):462-71. doi: 10.1038/ijo.2009.254. Epub 2009 Dec 22.

17.

Enhanced glucose metabolism in cultured human skeletal muscle after Roux-en-Y gastric bypass surgery.

Nascimento EB, Riedl I, Jiang LQ, Kulkarni SS, Näslund E, Krook A.

Surg Obes Relat Dis. 2015 May-Jun;11(3):592-601. doi: 10.1016/j.soard.2014.11.001. Epub 2014 Nov 13.

PMID:
25862179
18.

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, Caro JF.

J Clin Invest. 1992 Feb;89(2):701-5.

19.

Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal.

Chen MZ, Hudson CA, Vincent EE, de Berker DA, May MT, Hers I, Dayan CM, Andrews RC, Tavaré JM.

PLoS One. 2015 Apr 13;10(4):e0120084. doi: 10.1371/journal.pone.0120084. eCollection 2015.

20.

Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.

Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G.

Ann Surg. 2013 Mar;257(3):462-8. doi: 10.1097/SLA.0b013e318269cf5c.

PMID:
23388352

Supplemental Content

Support Center